Table 2.
Preventive and symptomatic treatment options for hand-foot syndrome.
| Preventative measures |
|---|
| Avoid mechanical stress/trauma (i.e. friction, pressure, tight footwear) |
| Avoid exposure to high temperatures around administration (e.g. bathing with hot water, vigorous exercise, wearing tight clothing and shoes) |
| Maintenance of good hygiene with regular visits to the podiatrist in case of corns and calluses |
| Referral to dermatologist for treatment of pre-existing dermatologic conditions |
| Moisturizing with urea-based cream three times per day (avoid excessive rubbing) |
| Local hypothermia (regional cooling) at time of administration (only for short-term infusions of PLD and docetaxel) |
| Symptomatic treatment |
| Pain: analgesics or topical anesthetics (lidocaine patches) |
| Inflammation: topical high-potency corticosteroids |
| Hyperkeratosis: topical keratolytics |
| Erosions: petroleum/lanolin-based ointments |
| NCI-CTC grade 2 or higher: oral celecoxib* |
| Other°: oral vitamin B6 (Pyridoxine) 400 mg, oral vitamin E, topical 99% dimethylsulfoxide (DSMU), topical sildenafil, oral corticosteroids |
PLD, pegylated liposomal doxorubicin; NCI-CTC, National Cancer Institute criteria for classification.
*Potential side effects include cardiovascular risks and upper gastrointestinal bleeding
°Limited or conflicting data.